Literature DB >> 28389819

Giant cell tumor of bone: imaging and histology changes after denosumab treatment : Comment on: von Borstel D, Taguibao RA, Strle NA, Burns JE. Giant cell tumor of the bone: Aggressive case initially treated with denosumab and intralesional surgery. Skeletal Radiol 2017;46:571-578.

Yaxia Zhang1,2, Hakan Ilaslan2,3, Thomas W Bauer4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28389819     DOI： 10.1007/s00256-017-2643-4

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  6 in total

1.  Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.

Authors:  Ilaria Girolami; Irene Mancini; Antonella Simoni; Giacomo Giulio Baldi; Lisa Simi; Domenico Campanacci; Giovanni Beltrami; Guido Scoccianti; Antonio D'Arienzo; Rodolfo Capanna; Alessandro Franchi
Journal:  J Clin Pathol       Date:  2015-09-03       Impact factor: 3.411

2.  Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.

Authors:  John Wojcik; Andrew E Rosenberg; Miriam A Bredella; Edwin Choy; Francis J Hornicek; G Petur Nielsen; Vikram Deshpande
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

3.  A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab.

Authors:  Isabella W Y Mak; Nathan Evaniew; Snezana Popovic; Richard Tozer; Michelle Ghert
Journal:  J Bone Joint Surg Am       Date:  2014-08-06       Impact factor: 5.284

4.  Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

Authors:  Sam Behjati; Patrick S Tarpey; Nadège Presneau; Susanne Scheipl; Nischalan Pillay; Peter Van Loo; David C Wedge; Susanna L Cooke; Gunes Gundem; Helen Davies; Serena Nik-Zainal; Sancha Martin; Stuart McLaren; Victoria Goodie; Ben Robinson; Adam Butler; Jon W Teague; Dina Halai; Bhavisha Khatri; Ola Myklebost; Daniel Baumhoer; Gernot Jundt; Rifat Hamoudi; Roberto Tirabosco; M Fernanda Amary; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Adrienne M Flanagan
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

5.  Radiological and pathological characteristics of giant cell tumor of bone treated with denosumab.

Authors:  Michiyuki Hakozaki; Takahiro Tajino; Hitoshi Yamada; Osamu Hasegawa; Kazuhiro Tasaki; Kazuo Watanabe; Shinichi Konno
Journal:  Diagn Pathol       Date:  2014-06-07       Impact factor: 2.644

6.  Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.

Authors:  Arjen H G Cleven; Saskia Höcker; Inge Briaire-de Bruijn; Karoly Szuhai; Anne-Marie Cleton-Jansen; Judith V M G Bovée
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.298
  6 in total
  3 in total

Review 1.  [Postoperative and posttherapeutic changes after primary bone tumors : What's important for radiologists?]

Authors:  T Grieser; I-M Nöbauer-Huhmann
Journal:  Radiologe       Date:  2017-11       Impact factor: 0.635

2.  Outcomes in Bone Giant Cell Tumors Treated With Surgical Resection With and Without Denosumab Injection: A Single-Institution Retrospective Study.

Authors:  Ali H AlYami; Abdulaziz Nazer; Hussam H Bashawieh; Albara A Dabroom; Majd Saem Aldahar; AlWaleed A AlYami; Bandar N AlMaeen
Journal:  Cureus       Date:  2022-07-14

Review 3.  Radiological findings of denosumab treatment for giant cell tumours of bone.

Authors:  Kirsten van Langevelde; Catherine L McCarthy
Journal:  Skeletal Radiol       Date:  2020-04-26       Impact factor: 2.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.